Cell Culture Conditions for Anlotinib Research

XIAOSHENG XU 1# , QUN WANG 1# , LIFEI SHEN 1 , YUHONG SHEN 1 , HUA LIU 1 , YAN LIU 1 , ZHIJIAN YANG 2 , ROBERT M. HOFFMAN 2,3 and WEIWEI FENG 1
McCoy's 5a Medium Modified (GIBCO) supplemented with 10% FBS and penicillin/streptomycin. All cells were grown and maintained at 37˚C in a humidified incubator with 5% CO 2 .
Anlotinib was a kind of gift from Chia Tai Tianqing Co., Ltd (Nanjing, PR China).

Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link: Access Free Full Text.

Xu X., Wang Q., Shen L., Shen Y., Liu H., Liu Y., Yang Z., Hoffman R.M, & Feng W. (2024). Anlotinib Inhibits Ovarian Cancer and Enhances Cisplatinum Sensitivity via Suppressing NOTCH2 Expression and Stemness. Anticancer research, 44(4).

Publication 2024

McCoy's 5a Medium Modified

Corresponding Organization :

Other organizations : Ruijin Hospital, Shanghai Jiao Tong University, AntiCancer (United States), University of California, San Diego

Top 5 similar protocols

Variable analysis

independent variables

Anlotinib

dependent variables

Cell growth and maintenance

control variables

McCoy's 5a Medium Modified (GIBCO) supplemented with 10% FBS and penicillin/streptomycin
Incubation at 37°C in a humidified incubator with 5% CO2

controls

Positive control: Not specified
Negative control: Not specified

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!